Mr Ryan Mebust, IMFT | |
2670 Woodman Center Ct, Kettering, OH 45420-1477 | |
(937) 439-0505 | |
(937) 293-0650 |
Full Name | Mr Ryan Mebust |
---|---|
Gender | Male |
Speciality | Marriage & Family Therapist |
Location | 2670 Woodman Center Ct, Kettering, Ohio |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1710285093 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
106H00000X | Marriage & Family Therapist | F1100002 (Ohio) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mr Ryan Mebust, IMFT 2670 Woodman Center Ct, Kettering, OH 45420-1477 Ph: (937) 439-0505 | Mr Ryan Mebust, IMFT 2670 Woodman Center Ct, Kettering, OH 45420-1477 Ph: (937) 439-0505 |
News Archive
A new histology needle for endoscopic ultrasound (EUS) from Cook Medical is now on the market, giving physicians the ability to retrieve tissue samples from hard-to-reach regions within or adjacent to the GI tract with a minimally invasive procedure.
The latest interim data from XPAND, AirXpanders Inc.'s U.S.-based, head-to-head pivotal study of its new, needle-free, patient-controlled tissue expansion system for mastectomy patients undergoing breast reconstruction, continue to show superior outcomes compared to traditional saline expanders including dramatically shorter expansion times, according to updated clinical data results presented at Plastic Surgery The Meeting, the annual scientific meeting of the American Society of Plastic Surgeons.
Federal officials are temporarily banning certain types of home health and ambulance providers in three major, high-fraud cities from enrolling in Medicare or Medicaid.
Mazor Robotics Ltd., a developer of innovative surgical robots and complementary products, today announced that Adachi Medical Instruments Co., Mazor's distribution partner in Japan, placed an order for its Renaissanceā¢ system. As part of the distribution agreement, Adachi is committed to obtain Japanese PMDA (Pharmaceuticals and Medical Devices Agency) approval for the Renaissance system.
AEterna Zentaris Inc. (the "Company"), a global biopharmaceutical company focused on oncology and endocrine therapy, today announced the initiation, by its partner Keryx Biopharmaceuticals Inc. ("Keryx") ( KERX), of a Phase 3 registration clinical trial for perifosine (KRX-0401), the Company's PI3K/Akt pathway inhibitor, in relapsed/refractory multiple myeloma patients.
› Verified 7 days ago
Amber Shanice Smith, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 2555 S Dixie Dr # 120, Kettering, OH 45409 Phone: 513-570-4068 | |
Kayla Hamilton, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 3085 Woodman Dr Ste 240, Kettering, OH 45420 Phone: 937-951-3077 Fax: 937-951-3109 |